BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guan MC, Wang MD, Liu SY, Ouyang W, Liang L, Pawlik TM, Xu QR, Huang DS, Shen F, Zhu H, Yang T. Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside. World J Gastrointest Oncol 2021; 13(4): 197-215 [PMID: 33889272 DOI: 10.4251/wjgo.v13.i4.197] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Guan M, Zhang S, Ding Q, Li N, Fu T, Zhang G, He Q, Shen F, Yang T, Zhu H. The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis. JCM 2023;12:949. [DOI: 10.3390/jcm12030949] [Reference Citation Analysis]
2 Guan MC, Ouyang W, Liu SY, Sun LY, Chen WY, Tong XM, Zhu H, Yang T. Alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease: A multicenter analysis. Hepatobiliary Pancreat Dis Int 2022;21:559-68. [PMID: 35643910 DOI: 10.1016/j.hbpd.2022.05.003] [Reference Citation Analysis]
3 Liu Y, Liang W, Chang Y, He Z, Wu M, Zheng H, Ke X, Lv M, Liu Q, Liu Q, Tang W, Huang Q, Lu Y, He M, Yang Q, Mo C, Wang J, Peng K, Min Z, Su H, Chen J. CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma. Front Immunol 2022;13:950884. [DOI: 10.3389/fimmu.2022.950884] [Reference Citation Analysis]
4 Benjamin I, Gber TE, Louis H, Ntui TN, Oyo-ita EI, Unimuke TO, Edim MM, Adeyinka AS. Modelling of Aminothiophene-Carbonitrile Derivatives as Potential Drug Candidates for Hepatitis B and C. Iran J Sci Technol Trans Sci 2022. [DOI: 10.1007/s40995-022-01355-w] [Reference Citation Analysis]
5 Qian Y, Itzel T, Ebert M, Teufel A. Deep View of HCC Gene Expression Signatures and Their Comparison with Other Cancers. Cancers (Basel) 2022;14:4322. [PMID: 36077860 DOI: 10.3390/cancers14174322] [Reference Citation Analysis]
6 Wang MD, Sun LY, Qian GJ, Li C, Gu LH, Yao LQ, Diao YK, Pawlik TM, Lau WY, Huang DS, Shen F, Yang T. Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort study. Int J Surg 2022;105:106843. [PMID: 35995351 DOI: 10.1016/j.ijsu.2022.106843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Alves AP, Rocha SM, Mamede AC, Braga PC, Alves MG, Oliveira PF, Botelho FM, Maia CJ. Differential response of hepatocellular carcinoma glycolytic metabolism and oxidative stress markers after exposure to human amniotic membrane proteins. Mol Biol Rep 2022. [PMID: 35716291 DOI: 10.1007/s11033-022-07598-5] [Reference Citation Analysis]
8 Huang L, Xu H, Wu T, Li G. Hedyotis diffusa Willd. Suppresses Hepatocellular Carcinoma via Downregulating AKT/mTOR Pathways. Evid Based Complement Alternat Med 2021;2021:5210152. [PMID: 34527062 DOI: 10.1155/2021/5210152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]